Takeda reports positive top-line outcomes from VISIBLE 1 trial
Takeda Pharmaceutical Company has reported positive top-line results from the VISIBLE 1 trial after meeting its primary endpoint.
Trial Takeda Pharmaceutical ulcerative colitis
Takeda Pharmaceutical Company has reported positive top-line results from the VISIBLE 1 trial after meeting its primary endpoint.